FMR CORP 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-12-12 08:41 am Sale |
2022-12-09 | 13G | Protagonist Therapeutics, Inc. PTGX |
FMR CORP | 385,863 0.784% |
-3,168,232 (-89.14%) |
Filing |
| 2022-06-10 11:04 am Sale |
2022-06-09 | 13G | Protagonist Therapeutics, Inc. PTGX |
FMR CORP | 3,554,095 7.304% |
-3,293,182 (-48.09%) |
Filing |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | Protagonist Therapeutics, Inc. PTGX |
FMR CORP | 6,847,277 14.346% |
394,513 (+6.11%) |
Filing |
| 2021-02-08 10:31 am Purchase |
2021-02-05 | 13G | Protagonist Therapeutics, Inc. PTGX |
FMR CORP | 6,452,764 15.079% |
2,371,797 (+58.12%) |
Filing |